North America Respiratory Inhalers Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type [Nebulizers, Metered Dose Inhalers (MDI), and Dry Powder Inhalers], Technology (Manually Operated Inhalers and Digitally Operated Inhalers), and Disease Indication (Asthma, COPD, Pulmonary Arterial Hypertension, and Others)

No. of Pages: 148    |    Report Code: BMIRE00028397    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Respiratory Inhalers Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Respiratory Inhalers Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Respiratory Inhalers Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising incidence of respiratory disorders
  • 5.1.2 Growing demand for portable inhalers
5.2 Market Opportunities
  • 5.2.1 Expansion in home healthcare
  • 5.2.2 Growth in digital health monitoring
5.3 Future Trends
  • 5.3.1 Development of smart inhalers with sensors
  • 5.3.2 Integration with health monitoring apps
5.4 Impact of Drivers and Restraints

6. North America Respiratory Inhalers Market Regional Analysis

6.1 North America Respiratory Inhalers Market Overview
6.2 North America Respiratory Inhalers Market Revenue 2020-2028 (US$ Million)
6.3 North America Respiratory Inhalers Market Forecast Analysis

7. North America Respiratory Inhalers Market Analysis – by Product Type

7.1 Nebulizers
  • 7.1.1 Overview
  • 7.1.2 Nebulizers: North America Respiratory Inhalers Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Metered Dose Inhalers
  • 7.2.1 Overview
  • 7.2.2 Metered Dose Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Dry Powder Inhalers
  • 7.3.1 Overview
  • 7.3.2 Dry Powder Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Respiratory Inhalers Market Analysis – by Technology

8.1 Manually Operated Inhalers and Digitally Operated Inhalers
  • 8.1.1 Overview
  • 8.1.2 Manually Operated Inhalers and Digitally Operated Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Respiratory Inhalers Market Analysis – by Disease Indication

9.1 Asthma
  • 9.1.1 Overview
  • 9.1.2 Manually Operated Inhalers and Digitally Operated Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.2 COPD
  • 9.2.1 Overview
  • 9.2.2 Manually Operated Inhalers and Digitally Operated Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Pulmonary Arterial Hypertension
  • 9.3.1 Overview
  • 9.3.2 Manually Operated Inhalers and Digitally Operated Inhalers: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Respiratory Inhalers Market – North America Analysis

10.1 North America
  • 10.1.1 North America Respiratory Inhalers Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 North America Respiratory Inhalers Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Respiratory Inhalers Market Breakdown, by Product Type
    • 10.1.1.1.2 US: North America Respiratory Inhalers Market Breakdown, by Technology
    • 10.1.1.1.3 US: North America Respiratory Inhalers Market Breakdown, by Disease Indication
  • 10.1.1.2 Canada: North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Respiratory Inhalers Market Breakdown, by Product Type
    • 10.1.1.2.2 Canada: North America Respiratory Inhalers Market Breakdown, by Technology
    • 10.1.1.2.3 Canada: North America Respiratory Inhalers Market Breakdown, by Disease Indication
  • 10.1.1.3 Mexico : North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Respiratory Inhalers Market Breakdown, by Product Type
    • 10.1.1.3.2 Mexico : North America Respiratory Inhalers Market Breakdown, by Technology
    • 10.1.1.3.3 Mexico : North America Respiratory Inhalers Market Breakdown, by Disease Indication

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Respiratory Inhalers Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 AstraZeneca Plc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Beximco Pharmaceuticals Ltd.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Boehringer Ingelheim International GmbH
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Cipla Ltd
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 GSK Plc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Koninklijke Philips NV
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 OMRON Corp
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 OPKO Health, Inc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 PARI Respiratory Equipment, Inc.
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Teva Pharmaceutical Industries Ltd
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

  1. AstraZeneca Plc
  2. Beximco Pharmaceuticals Ltd.
  3. Boehringer Ingelheim International GmbH
  4. Cipla Ltd
  5. GSK Plc 
  6. Koninklijke Philips NV
  7. OMRON Corp
  8. OPKO Health, Inc
  9. PARI Respiratory Equipment, Inc.
  10. Teva Pharmaceutical Industries Ltd
north-america-respiratory-inhalers-market